NCT06849661|Enrolling By Invitation
Loading search results
Sponsor study identifier
observational
360
1 country
1
Study Start
January 15, 2025
Actual (reported)Primary Completion
September 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
There are still complexities regarding the effects of anesthetic drugs on bilirubin metabolism. The aim of the study was to investigate whether preoperative serum bilirubin levels are associated with the length of hospital stay after ERCP performed under sedation anesthesia in the presence of propofol. Unstable hemodynamics, increased propofol sensitivity, and prolonged recovery time to anesthetics are common features encountered in patients with hyperbilirubinemia. Therefore, close monitoring of cardiovascular functions in these patients and awareness of the possible need for a reduction in the dose of anesthetic used are the expected benefits of the study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 15, 2025
Actual (reported)February 15, 2025
Actual (reported)February 27, 2025
Actual (reported)September 15, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Preoperative bilirubin levels and length of hospital stay
Patients' age, gender, weight in kilograms, height in centimeter, weight and height will be combined to report BMI in kg/m\^2, chronic disease history, medication history, smoking, alcohol, ASA status, being an inpatient or outpatient, Hb (hemoglobin), platelets, Na (sodium), K (potassium), INR (international normalized ratio), total bilirubin, direct bilirubin, indirect bilirubin, ALP (Alkaline phosphatase), ALT (Alanine aminotransferase), AST (aspartate aminotransferase), and hospital stay will be recorded by reviewing the case follow-up forms.
from the beginning of the enrollment until 1 month after sedation anesthesia recovery
The study will be conducted on patients who applied to the anesthesia polyclinic of SBU University Kanuni Sultan Süleyman E.A.H. and were scheduled to undergo ERCP under sedation. A total of 360 patients over the age of 18, ASA I-IV status, of both genders, who will undergo an ERCP procedure under sedation anesthesia will be included in the study.
Sağlık Bilimleri Üniversitesi Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi
Istanbul, 34000, Turkey (Türkiye)
Bilirubines (Total,direct,indirect), Amylase, AST, ALT, ALP
First Submitted
February 15, 2025
First Posted
February 27, 2025
Study Start
January 15, 2025
Actual (reported)Primary Completion
September 15, 2025
Estimated (date passed)Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial Surgery
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 27, 2025
Record last verified: 2025-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: